Chemed Reports Fourth-Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Chemed (CHE) PT Raised to $275 at Oppenheimer Following 4Q Beat
February 15, 2018 10:17 AM ESTOppenheimer raised its price target on Chemed (NYSE: CHE) to $275.00 (from $270.00) while maintaining a Outperform rating following the company's 4Q earnings report. CHE reported adjusted EPS of $2.32 vs. the Street's $2.27.
Following the quarter, Chemed issued impressive FY2018 EPS guidance of $10.60-$10.85, well... More
Chemed Corporation (CHE) Tops Q4 EPS by 5c
February 14, 2018 4:24 PM ESTChemed Corporation (NYSE: CHE) reported Q4 EPS of $2.32, $0.05 better than the analyst estimate of $2.27. Revenue for the quarter came in at $428 million versus the consensus estimate of $423.83 million.
GUIDANCE:
Chemed Corporation sees FY2018 EPS of $10.60-$10.85, versus the consensus of... More



